Noelle Baquiche

Yiannis Kiachopoulos

Angeliki Andrianopoulou

Magdalena Sommenvik

Artur Saudabayev

An interview with Imad Yassin on how AI is transforming translational research and why Causaly is one of the biggest game-changers he's seen to date.

How Causaly AI is transforming translational research

How Causaly AI is transforming translational research: Interview with Imad Yassin

At Causaly we're excited to announce a new partnership with University College
London (UCL) to help accelerate research into the...

Covid-19: Causaly partners with UCL to accelerate coronavirus research

Causaly uses artificial intelligence to rapidly read, understand and interpret vast databases of biomedical knowledge.

At Causaly, we're honored to be supporting the 2019-nCoV Collective Research Initiative led by the Global Health Drug Discovery Institute in Beijing (GHDDI).

Causaly provides Covid-19 dataset to Bill and Melinda Gates' funded Global Health Drug Discovery Institute

We're delighted to have been named in the Top 10 Greek founded companies to watch in 2020 by EU Startups. The list was compiled according to growth rate, team numbers, funding closed, sector and more.

Featured article

How Causaly AI is transforming translational research: Interview with Imad Yassin

Posts written by Noelle Baquiche

Sign up for Causaly newsletter